Plain-English translation of NCT06131801 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying how venetoclax—a medication used to treat blood cancers like leukemia and lymphoma—is absorbed and processed by the body when given as a liquid solution made from crushed tablets. Researchers want to understand how well this form of the medication works in children and young adults. By measuring the medication levels in blood samples, they hope to learn if this liquid version is as effective as other forms.
Many children with blood cancers cannot swallow pills easily, so doctors sometimes crush tablets and mix them into a liquid. This study exists to make sure the medication works the same way when given as a liquid and to help doctors know if they're giving the right dose.
You likely qualify if…
You likely don't qualify if…
You will continue taking the medication exactly as your cancer doctor prescribed—there are no changes to your treatment plan. The only difference is that researchers will draw blood samples at several time points to measure how much medication is in your bloodstream. These blood draws will be done through your existing central line or port, so no additional needle sticks are needed. The study simply tracks what's already happening in your body during your regular cancer care.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States